Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical Inc.

Analysts are intrested in these 5 stocks: ( ($NFLX) ), ( ($CSCO) ), ( ($ISRG) ), ( ($V) ) and ( ($PG) ). Here is a breakdown of their recent


Netflix, Cisco, ISRG, Visa, P&G Trending With Analysts

Barclays analyst Matt Miksic maintained a Buy rating on Intuitive Surgical on January 23 and set a price target of $712.00. The company’s shares cl...

Barclays Remains a Buy on Intuitive Surgical (ISRG)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intuitive Surgical (ISRG – Research Report) and Abbott Laboratori...

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG) and Abbott Laboratories (ABT)

Intuitive Surgical (($ISRG)) has held its Q4 earnings call. Read on for the main highlights of the call. Intuitive Surgical Balances Rapid Growth W...

Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Corcept Therapeutics (CORT – Research Report), Intuitive Surgical...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (ISRG – Research Report), OnKure ...

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), OnKure Therapeutics (OKUR) and Praxis Precision Medicines (PRAX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG – Research Report) and Kary...

Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)

Medical technology company Intuitive Surgical ($ISRG) is scheduled to announce its results for the fourth quarter of 2025 on January 22. ISRG is kn...

Intuitive Surgical (ISRG) Is About to Report Q4 Earnings. Here Is What to Expect

This week, several major companies will be reporting earnings. Among them are Intel (INTC), Netflix (NFLX), Johnson & Johnson (JNJ), GE Aerospace (...

Options Volatility and Implied Earnings Moves This Week, January 20 – January 23, 2026

U.S. stocks finished the week essentially flat as a semiconductor-led bid was offset by softer bank performance and a steady drumbeat of policy hea...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 18

Intuitive Surgical ($ISRG) announced an update on their ongoing clinical study. Intuitive Surgical’s New Imaging Drug Targets Safer Colorectal Surg...

Intuitive Surgical Advances Phase 3 Imaging Drug to Cut Ureter Injuries in Robotic Colorectal Surgery

In a report released on January 14, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Intuitive Surgical, with a price target of $650...

RBC Capital Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Bernstein analyst Lee Hambright maintained a Buy rating on Intuitive Surgical today and set a price target of $740.00. Hambright covers the Healthc...

Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Artificial intelligence remains a powerful long-term investment theme, and for investors who prefer ETFs over individual stocks, AI-focused funds o...

3 Best AI ETFs Investors Can’t Ignore in 2026

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Intuitive Surgical on January 7 and set a price target of $650.00. The company’s...

RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

U.S. chess champion Hikaru Nakamura has made some new additions as part of his TipRanks investment portfolio. As of January 6th, Hikaru has bought ...

Current Quarter	$1.63	Next Quarter	$2.01
Current Year	$8.24	Next Year	$9.5
QoQ Growth	+23.3%	YoY Growth	+15.3%
3Y EPS CAGR	+10.9%	Target Price	$625.62
Consensus	Buy	Upside	+30.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ISRG	$479.90	-3.39%	2.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ISRG	$479.90	-3.4%	2.03M
3
4
5
6

ISRG

ISRG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Intuitive Surgical Inc. Data in Excel

Get Intuitive Surgical Inc. Data in Excel